How can we help?
Alpha Feto Protein, Tumour Marker

Alpha Feto Protein, Tumour Marker

Also referred as
AFP
Tumour Marker
1,355+ booked recently
For men & women
Earliest reports in
29 hours
Contains
1 test
Know more about this test

An Alpha Feto Protein, Tumour Marker test measures the amount of a specific protein called Alpha-fetoprotein (AFP) in your blood. This protein is synthesized primarily in the liver and yolk sac of the fetus. This test aids in the management of cancers of the liver, ovaries, and testicles. However, AFP testing is not recommended as a screening procedure to detect cancer in the general population.

Samples required
Blood
Find out
Why is this test booked?
Preparation for this test
Sample Collection
Who will collect your samples?

Understanding Alpha Feto Protein, Tumour Marker

Alpha-fetoprotein (AFP), as the name suggests is a protein produced primarily by the liver in a developing baby (fetus). AFP levels are normally high during fetal life and then decline rapidly. In adults, raised serum AFP levels are seen either during pregnancy or in conjunction with several malignant diseases. Since the AFP levels are raised during pregnancy, the use of AFP as a tumor marker is not recommended in pregnant females.

In non-pregnant individuals, liver damage, and certain cancers can increase AFP levels significantly. This property of being on the higher side in cancerous lesions makes an Alpha Feto Protein, Tumour Marker test useful as a tumor marker test. Elevated levels of AFP are most commonly found in individuals with the most common type of liver cancer called hepatocellular carcinoma and in cancer of the testes (non-seminomatous). It is also raised in a rare type of liver cancer in infants called hepatoblastoma.

AFP may be elevated in non-cancerous conditions like liver diseases, such as hepatitis (acute viral hepatitis and chronic active hepatitis) and cirrhosis. Doctors usually recommend an Alpha Feto Protein, Tumour Marker test if an individual is suffering from conditions like liver cancer, testicular cancer, ovarian cancer, chronic hepatitis, etc. This test is also performed if an individual has been diagnosed with hepatocellular carcinoma or AFP-producing testicular cancer to help monitor your response to therapy and monitor for cancer recurrence.

No special preparation is required before undergoing an Alpha Feto Protein, Tumour Marker test. However, it is important to provide a brief clinical history or doctor's prescription at the time of sample collection. Also, tell your doctor about any medications you are taking as certain medications can potentially affect the AFP levels.

Lab test results may vary across different laboratories. When serial/repeat testing is being done, it is advisable to get tested from the same lab as test values may vary depending on the assay method used. All values should be correlated with clinical findings and results of other investigations.

Abnormal test results require an expert interpretation; therefore, never try to self-medicate at home based solely on these results, and always consult a doctor for a proper understanding of the test results. Doctors use an Alpha Feto Protein, Tumour Marker test not only for diagnostic purposes but also for monitoring cancer progression, assessing treatment response, and detecting potential cancer recurrence. While monitoring for cancer therapy, low concentrations of AFP are not necessarily indicative of the absence of disease. 

See more

What does Alpha Feto Protein, Tumour Marker measure?

An Alpha Feto Protein, Tumour Marker test that measures the level of AFP (alpha-fetoprotein) in your blood sample. Alpha-fetoprotein is a protein produced by the liver of a developing baby (fetus). AFP circulates through the fetal and maternal blood. It is present during pregnancy but disappears rapidly after birth. However, elevated AFP levels in adults can be a sign of liver disease, liver cancer, or cancers of the testes or ovaries. An Alpha Feto Protein, Tumour Marker can also be used for assessing response to ongoing treatment and monitoring for cancer recurrence.

FAQs related to Alpha Feto Protein, Tumour Marker

An Alpha Feto Protein, Tumour Marker test is typically performed to monitor certain diseases such as liver, testicular, and ovarian cancer. It can also be used to monitor the effectiveness of treatment for these types of cancer.
An Alpha Feto Protein, Tumour Marker is performed on a sample of blood. A needle is inserted into a vein, typically in your arm, to collect the blood sample. The blood sample is then sent to a laboratory, where the AFP levels are measured.
An individual may need an Alpha Feto Protein, Tumour Marker test if they experience symptoms suggestive of liver disease or cancer, or if the patient has certain risk factors for these conditions.
Certain medications and health conditions can affect the level of AFP. Pregnancy is one such condition that can significantly increase AFP levels, as the protein is produced in large amounts in the developing fetus.
High levels of AFP can be a sign of liver disease or certain types of cancer, including liver, testes, and ovaries. However, it's important to note that AFP is not solely specific to these conditions and elevated levels can also be seen in other situations.
An Alpha Feto Protein, Tumour Marker test is often used to monitor the effectiveness of treatment for certain types of cancer and may also be used to detect cancer recurrence. If AFP levels drop in response to treatment and then start to rise again, it may indicate that the cancer has returned.
In case, the levels of AFP are raised due to chronic liver infection or damage; an ultrasound exam, a CT scan, an MRI scan, or a biopsy for histopathological evaluation of tumor tissues are advised. A blood test for DCP (des-gamma carboxy prothrombin) is advised. It helps to detect liver cancer and monitor patients with hepatocellular carcinoma. Always consult your doctor before going ahead with additional tests.
Hepatocellular carcinoma is the most common type of primary liver cancer. It mostly occurs in people with chronic liver diseases such as cirrhosis which is caused by hepatitis B or C infection.
Hepatoblastoma is a very rare cancer that usually affects children less than 3-4 years of age. The development of this tumor starts in the liver. However, it does not spread to other parts of the body. This tumor is caused by a change in the gene. In addition to that, some other genetic health conditions can also increase a child’s risk of hepatoblastoma.

Alpha Feto Protein, Tumour Marker test price for other cities

Price inBangaloreRs. 899
Price inMumbaiRs. 949
Price inNew DelhiRs. 809
Price inGurgaonRs. 809
Price inKolkataRs. 809

How does home sample collection work?

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Download the Tata 1mg app. Trusted healthcare, at your fingertips.

Book tests, track reports, and get AI-powered health insights.

or
Conducted by
Tata 1mg Labs
Accredited labs
Highly skilled Phlebos
Verified reports
Who will collect your samples?
Tata 1mg certified phlebotomists
Contains 1 test
Alpha Feto Protein, Tumour Marker